To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
The Neurofunctional Imaging Group (GIN - IMN) and the company Fealinx (formerly Cadesis) inaugurated in Bordeaux on October 23 the joint Ginesislab laboratory. The objective of this laboratory is to optimize the use of biomedical imaging data by developing a specific computer platform.
A Research Team of the SCBM (Frédéric Joliot Institute), in collaboration with the SIMOPRO (Frédéric Joliot Institute), Strasbourg University and the start-up Syndivia, has just discovered a new chemical reaction allowing both to bind and to cleave molecules in biological media ("click and release" reaction).
An LSOD Research Team (I2BC@Saclay), in collaboration with a Research Team from Mar del Plata University (Argentina), has been able to characterize for the first time a NO-Synthase of plants. Researchers have shown that NO-Synthase from Ostreococcus tauri (pico plankton from the Thau lagoon) produces very large amounts of NO compared to human NO-synthases. However, terrestrial plants do not have NO-synthases and the biological role of this enzyme remains unknown.
For the first time, an animal model expresses the two biological characteristics of Alzheimer's disease. Researchers from MIRCen (François Jacob Institute), SPI (LEMM), Inserm, Universities Paris-Sud and Paris-Descartes and CNRS have developed an animal model that reproduces the progression of the human disease.
Two Research Teams led by Odette Prat of the Institute of Biosciences and Biotechnologies (BIAM) and Jean Armengaud of the Frédéric Joliot Institute (LI2D, Marcoule) have joined forces thanks to an ANR funding to deepen knowledge of the importance of the nature of protein crowns on the cellular impact of nanoparticles. The results from their three recent publications reveal a new concept: "the protein interactome applied to the corona of nanoparticles".
Brain Imaging and the largest MRI magnet in the world, on the program of the Science Festival on Saturday 14th & Sunday 15th October, at the sports center of Le Moulon. A success for CEA, IRFU and NeuroSpin!
The first joint scientific meeting of the Paris-Sud and Paris-Center nodes of the France Life Imaging Biology and Health Infrastructure was held on the 14th of September 2017, at the SHFJ in Orsay. The theme was the integration of heterogeneous imaging and biology data. Many researchers from the Frédéric Joliot Institute took part in this event attended by more than 100 people, including 1 / 5th of industrialists.
A Research Team in psychiatry at CEA-NeuroSpin, in collaboration with the Mondor Institute for Biomedical Research (INSERM) and Henri-Mondor University Hospitals, AP-HP, has shown that a genetic variant associated with multiple psychiatric disorders alters a network. prefronto-limbic, which would increase the risk of developing schizophrenia or bipolar disorder. The results of this study are published online October 2, 2017 in the Journal of Neuroscience.
Top page
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.